- Home
- MCHX vs INCR Comparison
MCHX vs INCR Comparison
Compare MCHX & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MCHX
- INCR
- Stock Information
- Founded
- MCHX 2003
- INCR 1994
- Country
- MCHX United States
- INCR Israel
- Employees
- MCHX N/A
- INCR N/A
- Industry
- MCHX Business Services
- INCR Biotechnology: Pharmaceutical Preparations
- Sector
- MCHX Consumer Discretionary
- INCR Health Care
- Exchange
- MCHX Nasdaq
- INCR Nasdaq
- Market Cap
- MCHX 84.3M
- INCR 76.7M
- IPO Year
- MCHX 2004
- INCR N/A
- Fundamental
- Price
- MCHX $1.63
- INCR $1.36
- Analyst Decision
- MCHX
- INCR
- Analyst Count
- MCHX 0
- INCR 0
- Target Price
- MCHX N/A
- INCR N/A
- AVG Volume (30 Days)
- MCHX 55.9K
- INCR 15.9K
- Earning Date
- MCHX 03-06-2025
- INCR 04-08-2025
- Dividend Yield
- MCHX N/A
- INCR N/A
- EPS Growth
- MCHX N/A
- INCR N/A
- EPS
- MCHX N/A
- INCR N/A
- Revenue
- MCHX $48,122,000.00
- INCR $72,420,918.00
- Revenue This Year
- MCHX $6.93
- INCR N/A
- Revenue Next Year
- MCHX $7.04
- INCR $39.30
- P/E Ratio
- MCHX N/A
- INCR N/A
- Revenue Growth
- MCHX N/A
- INCR N/A
- 52 Week Low
- MCHX $1.20
- INCR $1.17
- 52 Week High
- MCHX $2.40
- INCR $3.72
- Technical
- Relative Strength Index (RSI)
- MCHX 37.82
- INCR 32.14
- Support Level
- MCHX $1.63
- INCR $1.37
- Resistance Level
- MCHX $1.80
- INCR $1.49
- Average True Range (ATR)
- MCHX 0.10
- INCR 0.06
- MACD
- MCHX -0.02
- INCR -0.01
- Stochastic Oscillator
- MCHX 18.92
- INCR 16.01
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.
About INCR Intercure Ltd.
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.